Market Research Report
Vaccines Market by Technology, Indication, and End Use - Global Opportunity Analysis and Industry Forecast, 2017-2023
|Published by||Allied Market Research||Product code||539656|
|Published||Content info||240 Pages
Delivery time: 1-2 business days
|Vaccines Market by Technology, Indication, and End Use - Global Opportunity Analysis and Industry Forecast, 2017-2023|
|Published: May 1, 2017||Content info: 240 Pages||
Vaccine is a preparation of weak or killed pathogen to stimulate the immunity process of the body. The vaccine market is a segment under the pediatric drugs market, which accounts to 80% of the pharmaceutical drugs market. The demand for pediatric vaccines is the major driving force of the market. This is due to high birth rates in the developing countries that accounted to 97% in 2012. The major restraint is the side effects produced by the vaccines.
The opportunities of this market are the growing DNA vaccine market, which is easy to develop, low cost and few side effects. The challenges faced by this market are the development of vaccines. The vaccines are based on live organisms that have inherent variability. A small variation in the production process will significantly alter the biological property of the product.
The key players profiled in this report are: Abbott laboratories, Baxter International INC. GlaxoSmithKline PLC, Merck & CO. INC., Novartis AG, PFIZER, LG Life Sciences, Nippon Biologicals INC., Advaxis, Panacea biotec ltd.
Key Market segment:
Chapter: 1 INTRODUCTION
Chapter: 2 EXECUTIVE SUMMARY
Chapter: 3 MARKET OVERVIEW
Chapter: 4 VACCINES MARKET, BY TECHNOLOGY
Chapter: 5 VACCINES MARKET, BY END USE
Chapter: 6 VACCINES MARKET, BY INDICATION
Chapter: 7 VACCINES MARKET, BY REGION
Chapter: 8 COMPANY PROFILES